$14.58
Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant™
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 27.88%: Here's is How to Trade
Overview
52-week range
$7.56
$20
58% of range
Avg surprise (last 3)
+14.2%
Avg reaction (last 2)
-1.2%
50% positive
Latest IV / EM
106%
EM ±24.2% · $15 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.13 | $-0.19 | +31.6% | +38.1% | +0.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.11 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.26 | $-0.24 | -8.3% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.21 | $-0.26 | +19.2% | — | -3.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.19 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.32 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.36 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.19 | -$0.26 | +26.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22M | — | $27M | $24M | $23M | — | $21M | $19M |
| Cost of revenue | $4M | — | $6M | $5M | $5M | — | $6M | $5M |
| Gross profit | $18M | — | $21M | $18M | $17M | — | $15M | $14M |
| Operating income | $-6M | — | $-3M | $-7M | $-5M | — | $-4M | $-6M |
| Net income | $-7M | — | $-3M | $-9M | $-7M | — | $-5M | $-8M |
| EPS (diluted) | $-0.20 | — | $-0.11 | $-0.26 | $-0.21 | — | $-0.19 | $-0.26 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $22M | $21M | $23M | $27M | $13M | $15M | $13M |
| Inventory | $17M | $17M | $18M | $16M | $14M | $13M | $12M | $11M |
| Total current assets | $87M | $94M | $95M | $94M | $97M | $81M | $83M | $80M |
| Total assets | $99M | $106M | $107M | $106M | $110M | $95M | $96M | $94M |
| Long-term debt | $59M | $59M | $59M | $59M | $60M | $60M | $59M | $59M |
| Total liabilities | $84M | $87M | $89M | $87M | $86M | $87M | $86M | $85M |
| Total equity | $14M | $19M | $19M | $19M | $24M | $8M | $10M | $10M |